IP Library Granted Patent US 7,871,602
Granted Patent B2
US 7,871,602 · App. 12/244,907 · Granted Jan 18, 2011

Use of bis-amines to enhance the antimicrobial activity of aqueous compositions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,871,602
App. No.
12/244,907
Granted
Jan 18, 2011
Kind
B2
Abstract

The use of bis-amines to enhance the antimicrobial activity of pharmaceutical compositions is described. The bis-amines are particularly useful for enhancing the antimicrobial activity of aqueous ophthalmic compositions, such as artificial tears or ocular lubricants, and solutions for disinfecting contact lenses.

Claims (26)

1. A sterile aqueous ophthalmic composition comprising a bis-amine of the following formula, in an amount effective to enhance the antimicrobial activity of the composition:

wherein:

R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are independently selected from the group consisting of:

H; —CH 2 OH; and C 1 -C 5 straight or branched alkyl or alkenyl, optionally containing one or more heteroatoms, provided that no more than one of R1, R2 and R3 is —CH 2 OH, and no more than one of R4, R5 and R6 is —CH 2 OH; and

X is (—CH 2 —) w CHOH—CHOH(—CH 2 —) w , wherein w is a whole number of from 1 to 6 and the hydroxy groups are in either cis or trans configurations;

or a pharmaceutically acceptable salt thereof, said composition having a physiologically compatible pH and an osmolality of 210 to 320 mOsm/kg.

2. A composition according to claim 1 , wherein the bis-amine of formula (I) is 1,4-bis[isobutylamino]2,3-dihydroxy butane.

3. A method of enhancing the antimicrobial activity of a sterile, aqueous pharmaceutical composition, which comprises including an effective amount of a bis-amine in the composition, said bis-amine having the formula:

wherein:

R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are independently selected from the group consisting of:

H; —CH 2 OH; and C 1 -C 5 straight or branched alkyl or alkenyl, optionally containing one or more heteroatoms, provided that no more than one of R1, R2 and R3 is —CH 2 OH, and no more than one of R4, R5 and R6 is —CH 2 OH; and

X is (—CH 2 ) w —CHOH—CHOH(—CH 2 —) w , wherein w is a whole number of from 1 to 6 and the hydroxy groups are in either cis or trans configurations;

or a pharmaceutically acceptable salt thereof.

4. A method according to claim 3 , wherein the bis-amine of formula (I) is 1,4-bis[isobutylamino]2,3-dihydroxy butane.

5. The composition of claim 1 further comprising a borate.

6. The method of claim 3 wherein the composition further comprises a borate.

7. The composition of claim 1 further comprising at least one additional antimicrobial activity enhancing agent.

8. The composition of claim 7 , wherein the at least one additional antimicrobial activity enhancing agent is either an amidoamine or an amino alcohol.

9. The composition of claim 7 , wherein the at least one additional antimicrobial activity enhancing agent is selected from the group consisting of myristamidopropyl dimethylamine and 2-amino-2-methyl-1-propanol.

10. The method of claim 3 wherein the composition further comprises at least one additional antimicrobial activity enhancing agent.

11. The method of claim 10 , wherein the at least one additional antimicrobial activity enhancing agent is either an amidoamine or an amino alcohol.

12. The method of claim 10 , wherein the at least one additional antimicrobial activity enhancing agent is selected from the group consisting of myristamidopropyl dimethylamine and 2-amino-2-methyl-1-propanol.

13. The composition of claim 1 further comprising at least one antimicrobial agent.

14. The composition of claim 13 , wherein the at least one antimicrobial agent is selected from the group consisting of polyquaternium-1 and polyhexamethylene biguanide.

15. The method of claim 3 , wherein the composition further comprises at least one antimicrobial agent.

16. The method of claim 15 , wherein the at least one antimicrobial agent is selected from the group consisting of polyquaternium-1 and polyhexamethylene biguanide.

Assignments (3)
CONFIRMATORY DEED OF ASSIGNMENT EFFECTIVE APRIL 8, 2019 Recorded Dec 10, 2019
From: NOVARTIS AG
To: ALCON INC.
Reel/Frame 051454/0788 →
MERGER Recorded May 31, 2011
From: ALCON, INC.
To: NOVARTIS AG
Reel/Frame 026376/0076 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 10, 2010
From: DASSANAYAKE, NISSANKE L.; CAREY, THOMAS CHRISTOPHER; SCHLITZER, RONALD L.; MEADOWS, DAVID L.
To: ALCON, INC.
Reel/Frame 025470/0307 →